2 Clinical Trials for Various Conditions
This is a prospective clinical study to demonstrate a reduction in jowling and laxity of the jawline that can be achieved following facial volume enhancement using JUVÉDERM VOLUMA™ XC (0.3% w/w lidocaine). The secondary measure will be if this can be achieved with Jawline injection only, or if a superior result can be obtained with both cheek and jowl injection.
Study is to evaluate the efficacy of treatment Radio Frequency in premature jowl and neck laxity following facialplasty